This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Kumiai Chemical Industry Co., Ltd., Tohoku University, National Institute of Advanced Industrial Science and Technology. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022-2024
Title: Maiko Umemura: Innovator in Cyclic Peptide Synthesis
Introduction
Maiko Umemura is a prominent inventor based in Sapporo, Japan. She has made significant contributions to the field of biotechnology, particularly in the synthesis of cyclic peptide compounds. With a total of 2 patents, her work is paving the way for advancements in this area.
Latest Patents
Maiko's latest patents focus on a gene involved in the synthesis of cyclic peptide compounds. The inventions include a method for producing cyclic peptide compounds using the identified gene and a transformant comprising the same. These innovations aim to identify a gene cluster involved in the biosynthesis of cyclic peptide compounds produced by filamentous fungi. The gene is composed of modules that encode proteins with the activity of synthesizing nonribosomal peptides, which form the basic peptide backbone of cyclic peptide compounds.
Career Highlights
Throughout her career, Maiko has worked with esteemed institutions such as Tohoku University and Kumiai Chemical Industry Co., Ltd. Her research has significantly impacted the understanding and production of cyclic peptides, showcasing her expertise in the field.
Collaborations
Maiko has collaborated with notable colleagues, including Takashi Kubo and Masayuki Machida. These partnerships have further enhanced her research and contributions to the scientific community.
Conclusion
Maiko Umemura's innovative work in cyclic peptide synthesis exemplifies her dedication to advancing biotechnology. Her patents and collaborations reflect her significant role in this important field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile